Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
Volume 0.21M
Average 0.38M
LTGO Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
Net Change in Cash history
Currency unavailable · from the cash flow
No Net Change in Cash data reported for this period type.
Net Change in Cash vs competitors
How LTGO compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $172.46M USD | +253.2% | — | 21.7% | |
| LTM Mar 2026 | $139.3M USD | -239.9% | -37.4% | 19.0% | |
| LTM Mar 2026 | $2.45M USD | -180.9% | — | 7.2% | |
LTGOLatigo Biotherapeutics Inc. | — | — | — | — | — |
| Peer median (excluding LTGO) | — | -180.9% | -37.4% | 19.0% | |
Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.